Serum total bilirubin and new-onset hypertension in perimenopausal women: a cross-sectional study.
Journal
Menopause (New York, N.Y.)
ISSN: 1530-0374
Titre abrégé: Menopause
Pays: United States
ID NLM: 9433353
Informations de publication
Date de publication:
01 08 2022
01 08 2022
Historique:
pubmed:
13
7
2022
medline:
3
8
2022
entrez:
12
7
2022
Statut:
ppublish
Résumé
Previous studies have shown negative associations between total bilirubin (TBIL) and hypertension. However, the association of TBIL with new-onset hypertension in perimenopausal women is unknown. A total of 196 perimenopausal women were included in this cross-sectional study of which 85 had new-onset hypertension. All participants underwent 24-hour ambulatory blood pressure monitoring and a clinical assessment including anthropometrics. Sociodemographic, lifestyle, and menopausal symptoms (modified Kupperman Index [mKI]) were measured by questionnaire. A fasting blood sample was taken to measure a wide range of biomarkers and hormone levels. Restricted cubic spline regression was used to investigate potential nonlinearity. Multivariable logistic and robust linear regression analyses adjusting for minimal sufficient adjustment sets based on directed acyclic graphs were performed to test the association of TBIL with hypertension/blood pressure. We examined mKI-stratified analyses and a TBIL-mKI interaction term to explore potential effect modification by number of menopausal symptoms. Hypertensive women had significantly lower TBIL levels than did normotensive women (11.15 vs 12.55 μmol/L, P = 0.046). Univariate restricted cubic spline regression showed nonsignificant nonlinearity ( P value for nonlinearity, 0.339). Multivariable regression analyses adjusted for minimal sufficient adjustment sets revealed that higher TBIL level was associated with lower odds of hypertension (odds ratio, 0.91 per μmol/L TBIL; 95% confidence interval [CI], 0.84-0.98; P = 0.019). Total bilirubin showed a significant inverse association with average 24-hour diastolic blood pressure ( β = -0.36 mm Hg per μmol/L TBIL; 95% CI, -0.62 to -0.10; P = 0.008) but not with 24-hour systolic blood pressure ( β = -0.37 mm Hg per μmol/L TBIL; 95% CI, -0.79 to 0.06; P = 0.090). Stratified analyses suggested stronger inverse associations of TBIL with hypertension and 24-hour blood pressure in women with fewer menopausal symptoms (mKI ≤10), although the TBIL-mKI interaction was not significant. In perimenopause, TBIL was inversely associated with diastolic blood pressure and new-onset hypertension, diagnosed using 24-hour ambulatory blood pressure monitoring.
Identifiants
pubmed: 35819856
doi: 10.1097/GME.0000000000001999
pii: 00042192-990000000-00012
doi:
Substances chimiques
Bilirubin
RFM9X3LJ49
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
944-951Informations de copyright
Copyright © 2022 by The North American Menopause Society.
Déclaration de conflit d'intérêts
Financial disclosure/conflicts of interest: None reported.
Références
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet . 2018;392:1923–1994. doi:10.1016/s0140-6736(18)32225-6
doi: 10.1016/s0140-6736(18)32225-6
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16:223–237. doi:10.1038/s41581-019-0244-2
doi: 10.1038/s41581-019-0244-2
Pérez JA, Garcia FC, Palacios S, Pérez M. Epidemiology of risk factors and symptoms associated with menopause in Spanish women. Maturitas 2009;62:30–36. doi:10.1016/j.maturitas.2008.10.003
doi: 10.1016/j.maturitas.2008.10.003
Yang D, Haines CJ, Pan P, et al. Menopausal symptoms in mid-life women in southern China. Climacteric 2008;11:329–336. doi:10.1080/13697130802239075
doi: 10.1080/13697130802239075
Delamater L, Santoro N. Management of the perimenopause. Clin Obstet Gynecol 2018;61:419–432. doi:10.1097/grf.0000000000000389
doi: 10.1097/grf.0000000000000389
Sayakhot P, Vincent A, Teede H. Cross-cultural study: experience, understanding of menopause, and related therapies in Australian and Laotian women. Menopause 2012;19:1300–1308. doi:10.1097/gme.0b013e31825fd14e
doi: 10.1097/gme.0b013e31825fd14e
Robitaille Cynthia, Dai Sulan, Waters Chris, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012;184:E49–E56. doi:10.1503/cmaj.101863
doi: 10.1503/cmaj.101863
Olszanecka A, Pośnik-Urbańska A, Kawecka-Jaszcz K, Czarnecka D, Fedak D. Adipocytokines and blood pressure, lipids and glucose metabolism in hypertensive perimenopausal women. Kardiol Pol 2010;68:753–760. PMID: 20648430
Olszanecka A, Dragan A, Kawecka-Jaszcz K, Fedak D, Czarnecka D. Relationships of insulin-like growth factor-1, its binding proteins, and cardiometabolic risk in hypertensive perimenopausal women. Metabolism 2017;69:96–106. doi:10.1016/j.metabol.2017.01.005
doi: 10.1016/j.metabol.2017.01.005
Kunutsor SK, Bakker SJ, Gansevoort RT, Chowdhury R, Dullaart RP. Circulating total bilirubin and risk of incident cardiovascular disease in the general population. Arterioscler Thromb Vasc Biol 2015;35:716–724. doi:10.1161/atvbaha.114.304929
doi: 10.1161/atvbaha.114.304929
Memon N, Weinberger BI, Hegyi T, Aleksunes LM. Inherited disorders of bilirubin clearance. Pediatr Res 2016;79:378–386. doi:10.1038/pr.2015.247
doi: 10.1038/pr.2015.247
Vera T, Granger JP, Stec DE. Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II–dependent hypertension in mice. Am J Physiol Regul Integr Comp Physiol 2009;297:R738–R743. doi:10.1152/ajpregu.90889.2008
doi: 10.1152/ajpregu.90889.2008
Wang L, Bautista LE. Serum bilirubin and the risk of hypertension. Int J Epidemiol 2015;44:142–152. doi:10.1093/ije/dyu242
doi: 10.1093/ije/dyu242
Novák P, Jackson AO, Zhao GJ, Yin K. Bilirubin in metabolic syndrome and associated inflammatory diseases: new perspectives. Life Sci . 2020;257:118032. doi:10.1016/j.lfs.2020.118032
doi: 10.1016/j.lfs.2020.118032
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007;18:800–804. doi:10.1097/EDE.0b013e3181577654
doi: 10.1097/EDE.0b013e3181577654
Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol 2019;73:3018–3026. doi:10.1016/j.jacc.2019.03.507
doi: 10.1016/j.jacc.2019.03.507
Parati G, Stergiou G, O'Brien E, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014;32:1359–1366. doi:10.1097/HJH.0000000000000221
doi: 10.1097/HJH.0000000000000221
Ohkubo T, Imai Y, Tsuji I, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998;32:255–259. doi:10.1161/01.hyp.32.2.255
doi: 10.1161/01.hyp.32.2.255
Chinese eGFR Investigation Collaboration. Modification and evaluation of MDRD equation for Chinese patients with chronic kidney disease. Chin J Nephrol 2006;22:589–595. doi:10.3760/j.issn:1001-7097.2006.10.002
doi: 10.3760/j.issn:1001-7097.2006.10.002
Tao M, Shao H, Li C, Teng Y. Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women. Patient Prefer Adherence 2013;7:223–229. doi:10.2147/ppa.s42852
doi: 10.2147/ppa.s42852
Ye X, Yao Z, Xu Y, et al. Frequency-risk and duration-risk relations between second-hand smoke exposure and menopausal symptoms among middle-aged women in Guangzhou, China. Climacteric 2015;18:323–328. doi:10.3109/13697137.2014.964672
doi: 10.3109/13697137.2014.964672
Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010;29:1037–1057. doi:10.1002/sim.3841
doi: 10.1002/sim.3841
Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol . 2008;8:70. doi:10.1186/1471-2288-8-70
doi: 10.1186/1471-2288-8-70
Pearl J. An introduction to causal inference. Int J Biostat . 2010;6:Article 7. doi:10.2202/1557-4679.1203
doi: 10.2202/1557-4679.1203
Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package 'dagitty'. Int J Epidemiol 2016;45:1887–1894. doi:10.1093/ije/dyw341
doi: 10.1093/ije/dyw341
Chin HJ, Song YR, Kim HS, et al. The bilirubin level is negatively correlated with the incidence of hypertension in normotensive Korean population. J Korean Med Sci 2009;24 Suppl:S50–S56. doi:10.3346/jkms.2009.24.S1.S50
doi: 10.3346/jkms.2009.24.S1.S50
Kunutsor SK, Kieneker LM, Burgess S, Bakker SJL, Dullaart RPF. Circulating total bilirubin and future risk of hypertension in the general population: the Prevention of Renal and Vascular End-Stage Disease (PREVEND) prospective study and a mendelian randomization approach. J Am Heart Assoc . 2017;6:e006503 doi:10.1161/JAHA.117.006503
doi: 10.1161/JAHA.117.006503
Hou L, Li H, Si S, et al. Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: observational findings and Mendelian randomization studies. Atherosclerosis 2021;320:112–121. doi:10.1016/j.atherosclerosis.2020.12.005
doi: 10.1016/j.atherosclerosis.2020.12.005
Pflueger A, Croatt AJ, Peterson TE, et al. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 2005;288:F552–F558. doi:10.1152/ajprenal.00278.2004
doi: 10.1152/ajprenal.00278.2004
Madhavan M, Wattigney WA, Srinivasan SR, Berenson GS. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997;131:107–113. doi:10.1016/s0021-9150(97)06088-7
doi: 10.1016/s0021-9150(97)06088-7
Lederer DJ, Bell SC, Branson RD, et al. Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc 2019;16:22–28. doi:10.1513/AnnalsATS.201808-564PS
doi: 10.1513/AnnalsATS.201808-564PS
Williamson EJ, Aitken Z, Lawrie J, Dharmage SC, Burgess JA, Forbes AB. Introduction to causal diagrams for confounder selection. Respirology 2014;19:303–311. doi:10.1111/resp.12238
doi: 10.1111/resp.12238
Maruhashi T, Kihara Y, Higashi Y. Bilirubin and endothelial function. J Atheroscler Thromb 2019;26(8):688–696. doi:10.5551/jat.RV17035
doi: 10.5551/jat.RV17035
Xiao L, Harrison DG. Inflammation in hypertension. Can J Cardiol 2020;36:635–647. doi:10.1016/j.cjca.2020.01.013
doi: 10.1016/j.cjca.2020.01.013
Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension 2017;70:660–667. doi:10.1161/hypertensionaha.117.07802
doi: 10.1161/hypertensionaha.117.07802